KEVIN D FREEMAN

CIK 1522478 · last filed 2026-01-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$361.2K

Companies

2

Total Filings

51

Lifetime Open-Market Net

$389.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GALT Director 135,269 $2.67 $361.2K $368.6K 42 2026-01-21
GALECTIN THERAPEUTICS INC (GALTW) Delisted Director 29,726 $20.6K 7 2016-12-19

Recent Filings · Page 5 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-12-18 GALT Grant (A) $0 EDGAR
2017-12-08 GALT Buy (P) +8,400 $13.7K EDGAR
2016-12-19 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2015-07-08 GALECTIN THERAPEUTICS INC (GALTW) Delisted Mixed +21,643 $0 EDGAR
2015-06-02 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +2,083 $5.6K EDGAR
2014-08-18 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +1,000 $4.7K EDGAR
2013-11-19 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +1,000 $6.1K EDGAR
2013-05-30 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +1,000 $4.2K EDGAR
2013-04-01 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2011-07-19 Grant (A) $0
Showing 4150 of 51
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.